http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2147747-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72e2a023c558b51d973e979033b70490 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716283b4d47c7564eba0b73a2e3c1704 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 1998-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2000-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_071d176df181dc0c97436d7c7cfebffd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6680cd1c8b8c228d559000e0b85e9f21 |
publicationDate | 2000-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2147747-C1 |
titleOfInvention | Method for determining indications to administer antiproteolytic activity preparations in acute period of inflammatory and destructive cornea diseases |
abstract | FIELD: medicine. SUBSTANCE: method involves applying gelatin as enzyme reaction substratum being a component in photographic emulsion on exposed or developed X-ray film. Trypsin and tears mixture is added (at a dilution of 1: 20). The result is visually evaluated in semi-quantitative way based on lysis zone. Trypsin and tears concentration is selected to retain linear relationship between enzyme activity and antiproteolytic activity of tears. Antiproteolytic activity of tears is expressed in inhibition units determined from calibration curve built with aprotinine used as standard trypsin inhibitor. Antiproteolytic activity being equal to 2.5 inhibition units/ml and lower, protease inhibitor preparations are considered to be indicated. EFFECT: simplified method. 3 dwg |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2634293-C1 |
priorityDate | 1998-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.